deltatrials
Recruiting OBSERVATIONAL NCT07157839

Phosphorylated Tau Levels in Donated Blood (pTIDB)

Detection of Elevated Plasma pTau217 in Donated Human Blood Samples: Implications for Blood Transfusion Safety

Sponsor: National Institute on Aging (NIA)

Conditions Alzheimer&Amp;#39;s Disease
Updated 2 times since 2025 Last updated: Feb 9, 2026 Started: Aug 28, 2025 Primary completion: Nov 1, 2026 Completion: Nov 1, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Alzheimer&Amp;#39;s Disease, this trial is actively recruiting participants. The trial is conducted by National Institute on Aging (NIA) and has accumulated 2 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Oct 2025 – ~Feb 2026 · 4 months · monthly snapshotRecruiting~Feb 2026 – present · 6 months · monthly snapshotRecruiting

Change History

2 versions recorded

  1. Feb 2026 — Present [monthly]

    Recruiting

  2. Oct 2025 — Feb 2026 [monthly]

    Recruiting

    First recorded

Aug 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute on Aging (NIA)
  • The University of Texas Health Science Center, Houston
Data source: The University of Texas Health Science Center, Houston

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations